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Abstract - Embryonic development up to the blastocyst stage, implantation into the uterine wall and the development of 
the functional placenta are steps crucial for the establishment of normal pregnancy. Specific cells of the placenta, the 
trophoblast cells, invade the uterine stroma and spiral arteries, adapting them to pregnancy. Interleukin-6 is present in 
the human endometrium during the receptive phase and early pregnancy. Trophoblasts also produce IL-6, which was 
found to stimulate trophoblast invasion and migration in vitro. Here we show that the activity of MMP-9 may 
contribute to the observed increased invasion. In addition, in the HTR-8/SVneo trophoblast cell line IL-6 increases cell 
proliferation. 
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INTRODUCTION 
Development of the embryo to the stage of blas-
tocyst, implantation in to the uterine wall and the 
development of the functional placenta are crucial 
steps in the establishment of a normal pregnancy. 
Specific cells of the placenta, invasive trophoblast 
cells, colonize and invade the uterine stroma and 
spiral arteries, adapting them to pregnancy. The 
invasive properties of these trophoblastic cells, cal-
led extravillous trophoblast (EVT), are largely due 
to their ability to degrade the extracellular matrix 
(Fisher et al., 1985) by proteolytic enzymes. Matrix 
metalloproteinases 2 and 9 (MMP-2 and -9, respec-
tively) have been shown to be particularly relevant 
to this process (Librach et al., 1991; Bishof et al., 
1995). The process of implantation involves com-
plex interactions between uterine and embryonic 
cells.  
There is an ever-increasing wealth of data 
implicating various autocrine and paraine factors as 
modulators of trophoblast function. Some of the 
cytokines produced by trophoblasts and/or diverse 
decidual cell types relevant for the establishment of 
pregnancy have been reviewed recently (Salamo-
nsen et al., 2007). Interleukin-6 (IL-6) is a pleiotro-
pic cytokine that belongs to the family of gp130 
cytokines, all of which share an accessory signal 
transducing unit gp130. Apart from IL-6, this 
family includes the leukemia inhibitory factor (LIF), 
IL-11, cardiotrophin 1, ciliary neurotropic factor, 
oncostatin M and cardiotrophin-like cytokine/cyto-
kine-like factor (Dimitriadis et al., 2005). In 
addition to the involvement of IL-6 in various pro-
cesses such as the immune response, the acute 
phase reaction and hematopoesis, a significant role 
in reproduction is supported by data showing that 
IL-6-deficient mice have reduced fertility and a de-
creased number of viable implantation sites 
(Robertson et al., 2000). IL-6 is expressed in the 
human endometrium throughout the menstrual 
cycle (Tabibzadeh and Sun, 1992; Vandermolen et 
al., 1996). In decidua, IL-6 is expressed in stromal 
cells in vivo and in vitro (Lockwood et al., 2008) but 
also in human trophoblast. Cultured placenta from 
the first trimester of pregnancy releases IL-6 to the 
supernatant (Kameda et al., 1990). Kauma et al. 
(1993) found that IL-6 is expressed in both 
trophoblast and villous core compartments. 
Jauniaux et al. (1996) showed that both syncytiotro-
phoblast and extravillous trophoblasts (EVT) 
express IL-6. The expression of IL-6 mRNA decli-
ned with differentiation to syncytiotrophoblast 532 M.  JOVANOVIĆ  ET AL. 
(Stephanou et al., 1995). A receptor protein for IL-6 
(IL-6R) and gp130 have been detected in trop-
hoblasts (Nishino et al., 1990; Sawai et al., 1995).  
Interleukin-6 has previously been shown to 
increase cell migration and invasion in extravillous 
trophoblasts (Jovanović and Vićovac, 2009). In the 
HTR-8-SVneo cell line the integrins α5β1 and α1β1 
were implicated. In this study the additional 
effector molecules in extravillous trophoblast were 
sought among the MMPs by gelatin zymography 
using HTR-8/SVneo cells as a model. We also 
demonstrate the effect of IL-6 on cell proliferation 
and the survival of HTR-8/SVneo cells.  
MATERIALS AND METHODS 
Reagents and antibodies 
RPMI 1640 medium and fetal calf serum (FCS) were 
from PAA Laboratories (Linz, Austria). Recombi-
nant human IL-6 was from R&D Systems 
(UK&Europe). The following antibodies were used: 
mouse anti-human IL-6R (R&D Systems, 
UK&Europe), mouse anti-human Ki67 (Dako, Den-
mark), mouse anti-human M30 (Roche, Germany), 
mouse anti-human CD45 antibody (Serotec, UK). 
Antobiotic-antimycotic solution, Coomassie brilliant 
blue R-250, acrylamide, N, N′ -methylene-bis-acryl-
amide, N, N, N′ , N′ -tetramethylenediamine (TE-
MED) and [3-(4,5-Dimethylthiazol-2-yl)-2,5 diphe-
nyltetrazolium bromide; Thiazolyl blue] (MTT), 
were from the Sigma Chemical Company (St. Louis, 
USA). Biotinylated horse anti-mouse IgG, avidin-
biotinylated peroxidase complex (ABC) and dia-
minobenzidine (DAB) substrate kit for peroxidase 
and Hematoxylin were from Vector Laboratories, 
Burlingame, CA, USA. Alexa488
® goat anti-mouse 
IgG was from Invitrogen (USA). Tris was from ICN 
Biomedicals, Inc. (Aurora, Ohio, USA). All other 
reagents were of the best commercial grade available.  
Cell culture 
For immunocytochemical analysis HTR-8/SVneo 
cells were cultured on glass coverslips, with or 
without IL-6 (5 ng/ml) until approximately 80% 
confluence was reached, at 37 °C in a moist 
atmosphere with 5% CO2. The coverslips were then 
rinsed twice with PBS and fixed with ice-cold 
acetone-methanol (1:1) for 10 min. The coverslips 
were kept frozen until staining. 
For gelatin zymography, 100 000 HTR-8/SVneo 
cells were seeded in 300 μl RPMI 1640 with 5% FCS per 
well in 24-well plates. Cells were incubated at 37°C in a 
moist atmosphere with 5% CO2 until close to conflu-
ence. The cells were then carefully rinsed with warm s-
PBS, and 200 μl of serum-free RPMI 1640 with or 
without IL-6 (5 ng/ml). The cells were then incubated 
for another 24 h. Culture media were collected and 
centrifuged for 5 min at 2 000 rpm to remove cells. 
Protein concentrations were determined in super-
natants using a BCA protein assay kit (Pierce, USA). 
Flow cytometry 
Flow cytometry was used to evaluate the expression 
of IL-6R on HTR-8/SVneo cells. Dynabeads – M-
280 sheep anti-mouse IgG (Invitrogen, USA) were 
coated with mouse monoclonal anti-CD45 antibody 
(1:100) according to the manufacturer’s instructi-
ons. The coated beads were stored in PBS/0.1% BSA 
at 4°C until use. The HTR-8/SVneo cells (8 x 10
5 
cells/tube) were washed twice with cold PBS2 (PBS, 
2% FCS and 0.01% sodium azide) and permeabili-
zed with Fixation/Permeabilization Concentrate di-
luted in Fixation/Permeabilization diluent, 1:4 
(eBioscience, USA) overnight at 4°C. The cells were 
washed twice in permeabilization buffer (PB), dilu-
ted in deionized water (1:10) and incubated with an 
anti-IL-6R (1:10) antibody for 45 min at 4°C. After 
incubation and subsequent washing with PB, the 
cells were stained for 30 min with Alexa488
® goat 
anti-mouse IgG diluted 1:1000 in PB with 5% goat 
serum. Control cells were incubated with the secon-
dary antibody alone. Labeled cells were fixed with 
4% formalin and analyzed on an EPICS XL-MCL 
flow cytometer (Coulter, Krefeld, Germany).  
Determination of viable cell number 
The MTT test was used as an indicator of cell number 
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in 96-well plates in 100 μl of medium, at 20 000 
cells/well. The cells were allowed to adhere overnight 
in a humidified chamber with 5% CO2 at 37°C. The 
cells were then carefully rinsed with warm s-PBS and 
challenged with IL-6 (5 ng/ml) dissolved in medium 
so that the total culture volume was 200 μl. After 24 or 
48 h, the cells were carefully rinsed with warm s-PBS 
twice. 100 μl of MTT in 10% FCS/PBS (1 mg/ml) was 
added to each well. After incubation for 2 h at 37 °C, 
the medium was replaced by 1-propanol (100 μl/well) 
and the plates were vigorously shaken to ensure 
complete solubilization of blue formazan. Absorbance 
was measured at 540 nm using a Microplate reader 
(LKB) and cell numbers were determined using a 
standard curve obtained with 5x10
3, 1x10
4, 2x10
4, 
4x10
4, 6x10
4 or 8x10
4 cells/well. The experiment was 
repeated three times, n=12. 
Immunocytochemistry 
The cells on the coverslips were rehydrated in PBS 
for 5 min. Non-specific staining was blocked by 
quenching endogenous peroxidase activity with 1% 
hydrogen-peroxide for 30 min, and for non-specific 
binding of proteins by incubation in 1% casein in 
PBS for 10 min at room temperature (RT). The cells 
were then incubated either with the primary anti-
Ki67 antibody (1: 75) or with anti-M30 (1: 50) 
antibody for 2 h at RT. This was followed by 
incubation with biotinylated horse anti-mouse IgG 
secondary antibody (1: 200) for 30 min and the 
avidin-biotinylated peroxidase complex (ABC) for 
another 30 min. Between steps, the cells were 
washed with PBS. Reaction was visualized using 
DAB as a chromogen. The nuclei were visualized by 
hematoxylin staining. Negative controls were 
performed routinely. Omission of the primary 
antibody and use of non-immune serum in place of 
a specific antibody resulted in the complete absence 
of staining. The slides were then mounted and 
examined using a Reichert-Jung microscope with a 
Leica DC150 Digital Camera System (Wetzlar, 
Germany). Ki-67 and M30-positive cells out of 2 
000 total cells were counted on coverslips from 
three different experiments. The results are ex-
pressed as percentages relative to the control. 
Gelatin zymography 
HTR-8/SVneo cells were incubated as described 
above. Gelatinase activities in the serum-free 
conditioned media of the HTR-8/SVneo cells were 
determined using SDS-polyacrylamide gel 
zymography. Samples were electrophoresed on 
SDS-polyacrylamide gels containing 1 mg/ml of 
gelatin under non-reducing conditions. All samples 
to be compared were always run on the same gel. 
Twenty five μg of protein were loaded per lane. 
Following electrophoresis, the gels were washed 2 
times for 15 min in 2.5% Triton X-100 to remove 
SDS, and then washed in deionized H2O. After 
overnight incubation in a reaction buffer (50 mM 
Tris-HCl, pH 7, containing 5 mM CaCl2) at 37° C, 
the gels were stained with Coomassie brilliant blue 
R-250 for 30 min RT and destained in 30% 
methanol and 10% glacial acetic acid. Proteinase 
activity was observed as a clear band of digested 
gelatin. Gelatinase activity was semi-quantiated by 
densitometric analysis of zymograms using the 
ImageMaster TotalLab v2.01 program (Amersham 
Biosciences, UK). 
All zymography experiments were repeated at 
least three times in duplicate. 
Statistical analysis 
Statistical analysis of data was carried out with the 
Statistical Software Program, ver. 5.0 (Primer of 
Biostatistic, McGraw-Hill Companies, Inc., New 
York, NY, USA) using Student’s T-test with values 
considered significantly different when p <0.05. 
RESULTS 
Expression of IL-6R 
We have previously shown by immunocytoche-
mistry that HTR-8/SVneo cells express IL-6R 
(Jovanovic and Vicovac, 2009). In this study IL-6R 
w a s  a l s o  d e t e c t e d  i n  H T R - 8 / S V n e o  c e l l s  b y  f l o w  
cytometry (Figure 1). Flow cytometric analysis 
revealed that 52% of HTR-8/SVneo cells were 
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Determination of viable cell number 
One of the aims of the study was to investigate the 
effect of IL-6 on HTR-8/SVneo cell proliferation. 
To that end viable cell numbers were determined by 
the MTT test in IL-6-treated vs. untreated cultures. 
As we have previously shown (Jovanović and 
Vićovac, 2009), IL-6 (5 ng/ml) did not significantly 
change the HTR-8/SVneo cell number in treated 
cultures after 24 h of culture, while after 48 h there 
was a slight but significant increase in cell viability 
(106% relative to the control, p<0,01; Figure 2).  
The effect of IL-6 on Ki 67 and M30 expression 
To further investigate the possibility that IL-6 
might change HTR-8/SVneo cell proliferation, the 
expression of the proliferation marker Ki67 was 
studied by immunocytochemistry. Cells were 
cultured on coverslips until 80% confluence was 
reached (~72h) as described above, and stained for 
the Ki67 antigen (Figure 3A). Interleukin-6 had a 
stimulatory effect on HTR-8/SVneo cell prolifera-
tion, and the number of Ki67-positive cells in IL-6 
treated cultures was 142% of the control (p<0.05, 
Figure 3B). The effect of IL-6 on HTR-8/SVneo cell 
apoptosis was studied by immunocytochemistry for 
the expression of M30, a caspase-cleaved cyto-
keratin fragment (Figure 4A). The number of 
apoptotic cells was low in the control cultures (less 
than 1%). Treatment with IL-6 decreased the 
number of M30-positive cells to 50% of the control, 
which, however, was not significant (Figure 4B).   
Gelatin zymography 
To test a possibility that IL-6 exerts its effect via 
MMP-2 and MMP-9, their activity was studied 
using gelatin zymography. The activity was 
quantified by densitometric analysis. The data 
obtained demonstrated that the activity of both 
proteases was increased. IL-6 (5 ng/ml) increased 
the activity of MMP-2 to 115% of the control 
(Figure 5A), which was not statistically significant, 
while MMP-9 activity was stimulated to 140% of 
control (p<0.05, Figure 5B). 
DISCUSSION 
The HTR-8/SVneo cell line has been shown to pro-
duce IL-6, as reported in previous studies 
(Svinarich et al., 1996), including our group (Jova-
nović and Vićovac, 2009). The latter study by our 
group has shown by immunocytochemistry that IL-
6R is expressed in these cells. In the present work 
this finding was confirmed using flow cytometry 
which has shown that 52% of HTR-8/SVneo cells 
expressed this receptor. In our previous study, the 
short-term effects of IL-6 were studied on cell 
migration and cell invasion. Hence, cell viability 
 
Figure 1.  Expression of IL-6R in HTR-8/SVneo cells detected
cytofluorometrically. Specific staining is shown in grey, and
non-specific staining in white histogram.  
 
Figure 2.  The effect of IL-6 (5 ng/ml) on HTR-8 SV/neo viable
cell number in MTT test. Data are expressed as percent of
untreated control, values given as mean±SEM.   THE EFFEFCT OF IL 6 ON TROPHOBLAST  535 
and cell numbers were reported for the same 24 h 
interval. Since IL-6 is known to induce proliferation 
in many cell types, in this study the HTR-8/SVneo 
cell proliferation in IL-6-treated cultures was 
studied in more detail. After 24 h of culture, IL-6 
had no significant effect on cell viability in the MTT 
test (Jovanović and Vićovac, 2009). After 48 h of 
culture, however, there was a slight but significant 
increase in viable cell numbers (106% of the 
control). In order to investigate whether further 
culture with IL-6 would have an effect on cell 
proliferation and/or apoptosis, cells were cultured 
until close to confluence for approximately 72 h. 
The data obtained show that IL-6 increased Ki67-
positive cell numbers to 142% of the control, 
suggesting that IL-6 has a stimulatory effect on 
HTR-8/SVneo cell proliferation. IL-6 has been 
shown to stimulate the proliferation of other cell 
types such as the prostate cancer cell line PC-3m 
(Yifei et al., 2001), myeloma cell lines (Keller and 
Ershler., 1995; Hov et al., 2009), neuroblastoma 
cells (Ara et al., 2009), and vascular smooth muscle 
cells (Morimoto et al., 1991). On the other hand, 
IL-6 was also reported to reduce endometrial 
stromal cell proliferation (Zarmakoupis et al., 
1995). In our study, treatment with IL-6 decreased 
the number of M30-positive cells to 50% of the 
control, suggesting that IL-6 may also inhibit 
caspase-dependent apoptosis. However, the overall 
percentage of M30-positive cells was very low (less 
than 1%) in both treated and control cells and the 
data were not significant. IL-6 inhibited apoptosis 
of various cell types, such as gastric cancer AGS 
cells (Lin et al., 2001), advanced prostate cancer 
cells (Cavarretta et al., 2007), B-chronic 
lymphocytic leukaemia cells (Reittie i sar., 1996), 
neutrophils (Asensi et al., 2004), multiple myeloma 
Cells (Chauhan et al., 1997), etc. 
 
Figure 3. The effect of IL-6 on HTR-8/SVneo cell proliferation. Immunocytochemical detection of Ki-67 antigen in control or IL-6 
treated (5ng/ml) HTR-8/SVneo cell cultures (A). The effect of IL-6 on Ki67-positive cell numbers (B). Data are expressed as percent of 
untreated control, values given as mean±SEM; * p<0.05 536 M.  JOVANOVIĆ  ET AL. 
A previous study by another group has reported 
that IL-6 stimulates the activity of matrix 
metaloproteinases-2 and -9 in the cytotrophoblast 
but not their expression (Meisser et al., 1999). Since 
it was shown that this cytokine has a stimulatory 
effect on trophoblast invasion and migration, and 
that this increase can be partly attributed to an 
increase in integrin subunit expression (Jovanović 
and Vićovac, 2009), the possible involvement of 
MMPs was considered. We have investigated 
whether IL-6 had the same effect on MMP-2 and 
MMP-9 activity in HTR-8/SVneo cells using a 
gelatin zymography assay. The data obtained 
showed stimulation of both MMP-2 (115% of 
control, not significant) and MMP-9 (140%, 
p<0.05) activity by IL-6. Our data show for the first 
time that IL-6 has a stimulatory effects on MMPs in 
HTR-8/SVneo cells and that the effect is similar to 
that shown for isolated trophoblasts (Meisser et al., 
1999).  
The data reported here, taken together with our 
previous findings (Jovanovic and Vicovac, 2009), 
support the relevance of IL-6 for human 
trophoblasts. They show that it exerts multiple 
effects on the trophoblast cell line HTR-8/SVneo as 
a model for extravillous trophoblasts. Other authors 
have also shown that IL-6 may be important for the 
process of implantation, since the expression of IL-
6 and IL-6 receptor was altered in placentas from 
pre-eclamptic pregnancies, a pathological condition 
characterized by reduced trophoblast invasion 
among other symptoms (Zhao et al., 2008). In 
addition, IL-6-deficient mice have reduced fertility 
and fewer viable implantation sites (Robertson et 
al., 2000). Based on the data reported here we 
propose that this cytokine is relevant for 
trophoblast survival and is an important mediator 
of trophoblast invasion in vitro. This could bear 
relevance for the process of embryo implantation in 
vivo. 
 
Figure 4. The effect of IL-6 on HTR-8/SVneo cell apoptosis. Immunocytochemical detection of M30 antigen in control or IL-6 treated 
(5ng/ml) HTR-8/SVneo cell cultures (A). The effect of IL-6 (5 ng/ml) on M30-positive cell numbers (B). Data are expressed as percent 
of untreated control, values given as mean±SEM.   THE EFFEFCT OF IL 6 ON TROPHOBLAST  537 
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